Molecular You Precision Health Platform Selected to Showcase with BC Pavilion at Web Summit
On the heels of its nationwide U.S. direct-to-consumer launch, Molecular You has been selected for the Naturally Innovative Growth Summit
Vancouver, B.C. – May 22, 2025 – Molecular You, a leading molecular medicine company transforming preventative healthcare, will be featured as a select part of the BC Pavilion at Web Summit Vancouver. 2025 marks the North American debut of the globally renowned technology conference, taking place from May 27 to 30 at the Vancouver Convention Centre
The BC Pavilion is a curated space coordinated by the Naturally Innovative Alliance on the Web Summit exhibit floor, showcasing over 70 of British Columbia’s leading tech and innovation companies.
Molecular You has recently launched its direct-to-consumer offering across the United States. The company has pioneered a single blood test capable of analyzing over 250 biomarkers at once across metabolic, cardiovascular, cognitive, immune, and inflammatory systems.
Meet Molecular You at Web Summit Vancouver on May 29 and 30:
Thursday, May 29, 2025
- Event: Naturally Innovative Growth Summit
- Location: BC Pavilion, Booth E120, West Building, Exhibition Floor Level 00
- Featuring: Brandon Landry, Senior Product Manager, (11:10 – 12:00 Pitch Segment)
- Additional Information: BC Pavilion Stage Schedule
- Venue Map: Venue Map
The BC Pavilion is a collaboration between the Government of British Columbia, the Government of Canada, Invest Vancouver, Destination Vancouver, and InnovateBC.
Friday, May 30, 2025
- Location: Booth G103
- Featuring: Meet the Molecular You team and see a live demo of the platform
- Venue Map: Venue Map
Molecular You empowers clinicians and individuals with the tools to harness the power of molecular medicine and artificial intelligence using proteomics and metabolomics to generate risk profiles for more than 26 health conditions. Results are delivered via a secure digital dashboard with optional consults with longevity experts and science-backed, personalized lifestyle recommendations to support health and wellness goals.
“This isn’t just a new way to access a fragmented array of traditional lab tests. Molecular You captures a more complete picture of your health and predictive disease risk status with a multi-omic test using a single blood draw,” said Jim Kean, CEO of Molecular You. “This is especially powerful for conditions like Alzheimer’s, PCOS, and autoimmune diseases, where no single biomarker tells the whole story. Studies also show this approach can detect disease sooner than standard diagnostics.”
Molecular You has accurately detected stage 1 pancreatic cancer in a symptom-free 60-year-old woman, enabling early intervention and successful removal without further treatment, demonstrating its real-world, life-saving potential.
“Most diagnostics tell you what’s already gone wrong, but by measuring the underlying biochemical pathways that underpin and drive disease, we’re making it possible to get ahead of disease instead of reacting to it,” said Molecular You’s Chief Medical Officer, Dr. Murdoc Khaleghi. “We focus on using advanced biomarkers that traditional diagnostic labs don’t offer and that top longevity physicians rely on.
To learn more or book your assessment, visit MolecularYou.com.
-##-
About Molecular You
Molecular You empowers clinicians and individuals with the tools to harness the power of molecular medicine and artificial intelligence to maximize health outcomes. Its comprehensive blood analysis uses proteomics and metabolomics to measure and track over 250 biomarkers and generate risk profiles for more than 26 health conditions. The platform delivers personalized lifestyle, diet, and supplement recommendations to support longevity, chronic disease management, and early disease prevention. Clinical practices increasingly leverage Molecular You to maximize patient outcomes through predictive, preventative, and precision medicine. Learn more: https://www.molecularyou.com/
View Similar Articles